Healthcare
Live Price
Offline$2.02
-10.22% today
1Y Change
-46.24%
Window
Jun 23, 2025 → Jun 5, 2026
Coverage: 240 bars · Jun 23, 2025 → Jun 5, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Pluri Inc. (PLUR) is a Healthcare stock with a market cap of $30.00M and listed on NASDAQ. The stock last traded around $2.02 and down 46.2% across the available one-year price window (Jun 23, 2025 → Jun 5, 2026). Baseline metrics include revenue growth of +309.8%, EPS growth of +10.8%, a dividend yield of 0.0%. What stands out right now is revenue +309.8%, EPS +10.8%, free cash flow -8.1% with operating margin -1857.9% and ROIC -92.9%. Valuation already assumes a fairly strong business story at price/sales 20.4. Overall, the current profile looks closer to a higher-growth but lower-margin setup than a generic broad-market placeholder. Stock Foundry combines PLUR price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Benchmark Comparison
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
PLUR
—
Normalized return
SPY
—
S&P 500
Excess Return
—
Relative to SPY
PLUR Max Drawdown
-60.28%
Trailing 1Y
SPY Max Drawdown
—
Trailing 1Y
Uses the longest available daily history for PLUR and SPY.
Financial profile
Profitability, balance sheet stamina, and cash efficiency drawn from the latest filings.
FY Revenue
$0.0
-100.0% YoY
FY Net Income
-$49.9M
-20.9% YoY
Free Cash Flow
-$31.3M
+14.9% YoY
Revenue Growth
+309.8%
EPS Growth
+10.8%
Gross Margin
21.3%
Net Margin
-1952.1%
Income statement
USD
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 1M | 326K | 287K | 234K | 0 |
| Gross Profit | 654K | 322K | 278K | -819K | -1M |
| Operating Income | -22M | -22M | -27M | -42M | -51M |
| EBITDA | -22M | -20M | -28M | -39M | -48M |
| Net Income | -23M | -21M | -28M | -41M | -50M |
| EPS (Diluted) | — | — | — | — | — |
Balance sheet
USD
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Cash & Equivalents | 6M | 7M | 5M | 10M | 31M |
| Total Assets | 39M | 40M | 51M | 68M | 94M |
| Total Liabilities | 40M | 34M | 35M | 36M | 36M |
| Shareholder Equity | -7M | 96K | 13M | 30M | 57M |
| Total Debt | 34M | 30M | 30M | 29M | 25M |
| Net Debt | 28M | 23M | 25M | 19M | -7M |
Cash flow positioning
Latest Full Year
Operating Cash Flow
31M
+15.3% YoY
Capital Expenditures
373K
-33.2% YoY
Free Cash Flow
31M
+14.9% YoY
Key ratios
Gross Margin
21.3%
Operating Margin
-1857.9%
Net Margin
-1952.1%
ROE
280.4%
Debt / Equity
-2.79x
Next Step
Use the numbers to decide whether this is a growth candidate, a quality compounder, or just an interesting outlier.